Skip to content

Targeted metabolomics identifies associations of plasma ceramides and their ratios with incident type 2 diabetes mellitus.

Aug 2026 · Acta Diabetologica · 0 citations · 37 references
Medicine

TL;DR

Distinct plasma ceramides are associated with the T2DM risk and Cer(d18:1/24:0) serves as the strongest predictive marker and ceramic ratios are particularly robust independent predictors of incident T2DM.

View source

Similar papers

Open access Sep 2026

Circulating PCSK9: A new frontier in cancer risk stratification for obese diabetics.

This study investigated potential plasma biomarkers associated with cancer risk and mortality in patients with type 2 diabetes mellitus (T2DM), a population known to have an increased cancer incidence and poorer outcomes compared with non-diabetic individuals. Traditional metabolic indicators, including blood pressure,...

Lien-Cheng Tsao, Chen-Ling Kuo, Yu-Shan Cheng et al. · 0 citations
Open access Sep 2026

Serum FAM19A5 in newly diagnosed type 2 diabetes mellitus and its association with metabolic and inflammatory parameters

Serum FAM19A5 levels were lower in newly diagnosed T2DM and remained independently associated with diabetes status after adjustment for BMI, HOMA-IR, and hs-CRP, and further investigation of FAM19A5 as a molecule of potential mechanistic interest, but not as a clinically useful diagnostic biomarker is supported.

H. S. Küçükerdem, G. Bozkaya, Ismail Demir · 0 citations
Open access Oct 2026

Serum sLOX-1 and 25-Hydroxyvitamin D3 Across the Glycemic Spectrum: Associations with Metabolic and Microvascular Parameters in Prediabetes and Type 2 Diabetes

Background/Objectives: Oxidative endothelial injury and vitamin D deficiency have independently been implicated in diabetic vascular complications, yet their distribution across the glycemic spectrum, from normoglycemia through prediabetes to established type 2 diabetes, has not been systematically characterised. This...

M. Alagöz, M. Adaş, Y. Gokden et al. · 0 citations
#protein folding Open access Nov 2026

P-123: Proteomic evidence of exocrine pancreatic involvement in type 1 diabetes

Persistent downregulation of pancreatic digestive enzymes supports exocrine pancreatic involvement as a durable feature of T1D, remaining evident in adolescents more than a decade after diagnosis despite good metabolic control and widespread use of advanced diabetes technologies.

M. Taube, D. Swolin-Eide, A. P. Lyckå et al. · 0 citations
Open access Oct 2026

Exploratory Untargeted Serum Lipidomics Identifies Altered Phospholipid and Glycerolipid Features in Established Type 2 Diabetes Mellitus

Background: Type 2 diabetes mellitus (T2DM) is associated with dysregulated lipid metabolism, but the serum lipid species associated with established T2DM may vary across populations and analytical platforms. We conducted an exploratory cross-sectional untargeted lipidomic analysis to characterize serum lipid features...

J. Al-Aama, H. B. Al Mahdi, Rawabi Zahed et al. · 0 citations
Open access Nov 2026

Serum Metabolic Alterations in Children with Type 1 Diabetes Mellitus: Exploratory Targeted Metabolomics

Background: Type 1 diabetes mellitus (T1DM) is an increasingly common chronic disease caused by autoimmune damage to pancreatic beta cells. Metabolomic profiling may provide insights into metabolic disturbances associated with T1DM and identify candidate biomarkers. Methods: The study included 29 children with T1DM and...

E. Samborowska, M. Wysocka-Mincewicz, A. Ochocińska et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.